Guggenheim analyst Michael Schmidt maintained a Buy rating on Compass Therapeutics (CMPX – Research Report) today and set a price target of ...
TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $389.00. The company’s ...
Teacher Retirement System of Texas increased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 26.4% ...